Disease-modifying drugs in relapsing-remitting multiple sclerosis: evidence-based treatment algorithm for Latin America

被引：0
|
作者：
Finkelsztejn, A.
Gabbai, A. A.
Fragoso, Y. D.
Carra, A.
Macias-Islas, M. A.
Arcega Revilla, R.
Garcia Bonitto, J.
Oehninger Gatti, C. L.
Orozco Escobar, G.
Tarulla, A.
Vergara, F.
Vizcarra, D.
机构：
[1] Hosp Clin, Porto Alegre, RS, Brazil
[2] Univ Fed Sao Paulo, Sao Paulo, Brazil
[3] Univ Metropolitana Santos, Santos, Brazil
[4] Hosp Britan, Buenos Aires, DF, Argentina
[5] Univ Guadalajara, CUCS, Guadalajara 44430, Jalisco, Mexico
[6] Inst Mexicano Seguro Social, Hosp Especialidades, Puebla, Mexico
[7] Colombian Multiple Sclerosis Res & Treatment Comm, Bogota, Colombia
[8] Hosp Clin Montevideo, Montevideo, Uruguay
[9] Hosp Patrocinio Penuela Ruiz, San Cristobal, Venezuela
[10] Inst Invest Med Alfredo Lanari, Buenos Aires, DF, Argentina
[11] Univ Los Andes, Santiago, Chile
[12] Univ Peruana Cayetano Heredia, Lima, Peru
来源：
MULTIPLE SCLEROSIS JOURNAL | 2011年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P997
引用
收藏
页码：S452 / S453
页数：2
相关论文
共 50 条
  • [31] ESTIMATING THE FISCAL CONSEQUENCES OF INVESTMENTS IN DISEASE-MODIFYING THERAPIES FOR THE TREATMENT OF RELAPSING-REMITTING MULTIPLE SCLEROSIS IN ITALY
    Mennini, F. S.
    Kotsopoulos, N.
    Connolly, M.
    Gianinazzi, M.
    Pellirone, M.
    Marcellusi, A.
    VALUE IN HEALTH, 2020, 23 : S627 - S628
  • [32] Disease-modifying effect of circuit class therapy in patients with relapsing-remitting multiple sclerosis
    Kolcava, J.
    Vlckova, E.
    Kocica, J.
    Sladeckova, M.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 395 - 396
  • [33] Cost of care according to disease-modifying therapy in Mexicans with relapsing-remitting multiple sclerosis
    Macias-Islas, Miguel A.
    Soria-Cedillo, Isaac F.
    Velazquez-Quintana, Merced
    Rivera, Victor M.
    Baca-Muro, Veronica I.
    Lemus-Carmona, Edith A.
    Chiquete, Erwin
    ACTA NEUROLOGICA BELGICA, 2013, 113 (04) : 415 - 420
  • [34] The Disease-Modifying Therapies of Relapsing-Remitting Multiple Sclerosis and Liver Injury: A Narrative Review
    Marco Biolato
    Assunta Bianco
    Matteo Lucchini
    Antonio Gasbarrini
    Massimiliano Mirabella
    Antonio Grieco
    CNS Drugs, 2021, 35 : 861 - 880
  • [35] Treatment satisfaction with injectable disease-modifying therapies in patients with relapsing-remitting multiple sclerosis (the STICK study)
    Fernandez, Oscar
    Duran, Eduardo
    Ayuso, Teresa
    Hernandez, Luis
    Bonaventura, Inmaculada
    Forner, Mireia
    PLOS ONE, 2017, 12 (10):
  • [36] Cost of care according to disease-modifying therapy in Mexicans with relapsing-remitting multiple sclerosis
    Miguel A. Macías-Islas
    Isaac F. Soria-Cedillo
    Merced Velazquez-Quintana
    Victor M. Rivera
    Verónica I. Baca-Muro
    Edith A. Lemus-Carmona
    Erwin Chiquete
    Acta Neurologica Belgica, 2013, 113 : 415 - 420
  • [37] Disease-Modifying Therapies for Relapsing-Remitting Multiple Sclerosis: A Network Meta-Analysis
    Lucchetta, Rosa C.
    Tonin, Fernanda S.
    Borba, Helena H. L.
    Leonart, Leticia P.
    Ferreira, Vinicius L.
    Bonetti, Aline F.
    Riveros, Bruno S.
    Becker, Jefferson
    Pontarolo, Roberto
    Fernandez-Llimos, Fernando
    Wiens, Astrid
    CNS DRUGS, 2018, 32 (09) : 813 - 826
  • [38] A Health-Economic Evaluation of Disease-Modifying Drugs for the Treatment of Relapsing-Remitting Multiple Sclerosis From the German Societal Perspective
    Nuijten, Mark
    Mittendorf, Thomas
    CLINICAL THERAPEUTICS, 2010, 32 (04) : 717 - 728
  • [39] The Disease-Modifying Therapies of Relapsing-Remitting Multiple Sclerosis and Liver Injury: A Narrative Review
    Biolato, Marco
    Bianco, Assunta
    Lucchini, Matteo
    Gasbarrini, Antonio
    Mirabella, Massimiliano
    Grieco, Antonio
    CNS DRUGS, 2021, 35 (08) : 861 - 880
  • [40] Assessing the net clinical benefit and absolute risk reduction of disease-modifying drugs in relapsing-remitting multiple sclerosis
    AL-Sabbagh, A.
    Bennett, R.
    Divan, V.
    Singer, B.
    JOURNAL OF NEUROLOGY, 2007, 254 : 137 - 137
12345